Please assess the completion status of the following clinical trial:

Trial Title: WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Ages 18 - 75 years, inclusive~* Diagnosed with type 2 diabetes~* Stable insulin therapy for 6 weeks~* Stable dose of any other antidiabetic medications for 90 days~* Hemoglobin A1c value between 7.5% to 9.5%~* C peptide greater than 0.5 ng/mL~* Prescribed ADA diet~Exclusion Criteria:~* History of type 1 diabetes or ketoacidosis~* History of pancreatitis~* Uncontrolled hypertension~* Allergy or toxic response to colesevelam or any of its components~* Serum LDL-C less than 60 mg/dL~* Serum TG greater than 500 mg/dL~* Body mass index (BMI) greater than 45 kg/m2-

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).